Tofacitinib, An Oral Janus Kinase Inhibitor: Post-Hoc Analyses of Efficacy and Safety of Monotherapy Vs Combination Therapy in a Phase 3 Rheumatoid Arthritis (Ra) Population

Cook, N., Nash, P., Hall, S., Thirunavukkarasu, K., Witcombe, D., Krishnaswami, S., Hoffman, E. and Connell, C. (2015). Tofacitinib, An Oral Janus Kinase Inhibitor: Post-Hoc Analyses of Efficacy and Safety of Monotherapy Vs Combination Therapy in a Phase 3 Rheumatoid Arthritis (Ra) Population. In: Internal Medicine Journal. , , (30-30). .

Author Cook, N.
Nash, P.
Hall, S.
Thirunavukkarasu, K.
Witcombe, D.
Krishnaswami, S.
Hoffman, E.
Connell, C.
Title of paper Tofacitinib, An Oral Janus Kinase Inhibitor: Post-Hoc Analyses of Efficacy and Safety of Monotherapy Vs Combination Therapy in a Phase 3 Rheumatoid Arthritis (Ra) Population
Proceedings title Internal Medicine Journal   Check publisher's open access policy
Journal name Internal Medicine Journal   Check publisher's open access policy
Publication Year 2015
Sub-type Published abstract
ISSN 1444-0903
Volume 45
Start page 30
End page 30
Total pages 1
Language eng
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Conference Paper
Collection: WoS Import
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Google Scholar Search Google Scholar
Created: Sun, 07 Jun 2015, 01:01:25 EST by System User